Occlutech

Occlutech is a leading specialist provider of minimally invasive cardiac devices, with a mission to improve the quality of life for people with heart conditions. Since 2003, Occlutech has developed, produced, and commercialized first-class, minimally invasive, cardiac implants for Congenital Heart Disease, Stroke Prevention, and Heart Failure, all with the mission to improve patients’ lives and address unmet medical needs. The devices are sold to hospitals and clinics in over 80 countries and used by physicians in implantation procedures. Registered in Switzerland, Occlutech employs around 330 people and has manufacturing and R&D facilities in Germany and Türkiye, a global finance and distribution hub located in Helsingborg, Sweden, as well as clinical operations in Minneapolis, U.S.